Internal Reference Number: FOI_6971
Date Request Received: 17/01/2023 00:00:00
Date Request Replied To: 25/01/2023 00:00:00
This response was sent via: By Email
Request Summary: The diagnosis and treatment of Spinal Muscular Atrophy
Request Category: Companies
| Question Number 1: How many patients have a current diagnosis for Spinal Muscular Atrophy (ICD-10 Code G12.0, G12.1, G12.8 and G12.9) at your trust? | |
| Answer To Question 1: Answer: 17 - For patients who have ever been diagnosed with the supplied ICD-10 codes and who haven’t died (according to local records). | |
| Question Number 2: How many patients have been treated in the last 4 months (September to December 2022) with the following products: Evrysdi (Risdiplam) - total patients Spinraza (Nusinersen) - total patients Zolgensma (Onasemnogene) - total patients Evrysdi (Risdiplam) - new* patients Spinraza (Nusinersen) - new* patients Zolgensma (Onasemnogene) - new* patients *new patients are defined as patients who were not treated with any of Spinraza (Nusinersen), Evrysdi (Risdiplam) or Zolgensma (Onasemnogene) in the previous 4-month period (May to August 2022). | |
| Answer To Question 2: Answer = 0 | |
| Question Number 3: Of the total patients treated in the last 4 months (September to December 2022) with Evrysdi (Risdiplam), please provide the number of patients that were treated with Spinraza (Nusinersen) in the previous 4 months (May to August 2022). | |
| Answer To Question 3: Answer = 0 | |
| Question Number 4: Of the total patients treated in the last 4 months (September to December 2022) with Zolgensma (Onasemnogene), please provide the number of patients that were treated with Spinraza (Nusinersen) in the previous 4 months (May to August 2022). | |
| Answer To Question 4: Answer = 0 | |
| Question Number 5: How many patients have been treated with Zolgensma (Onasemnogene) in the last 12 months (January to December 2022)? | |
| Answer To Question 5: Answer = 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
